Loading...

BGLC BIONEXUS GENE LAB CORP Capital Structure Changes 8-K Filing

BNXS

BGLC

BIONEXUS GENE LAB CORP

(BGLC)

2025 8-K

Show Summary

Summary

Shareholder Meeting

Strategic Partnership

Ethereum Strategy

Nasdaq Compliance

Delisting Notification

Director Resignations

Annual Meeting Results

Biogas Collaboration

Strategic Agreement

Expansion Plans

Co-Investment Announcement

Strategic Investment

Amendment of Service Contract

Management Changes

Resignation of CFO

Amendment - Disclosure of F...

Appointment of CEO

Resignation of CEO

Management Changes

Equity Offerings

External Links:

BIONEXUS GENE LAB CORP executed a 1-for-10 reverse stock split effective April 7, 2025, reducing shares from 17,967,663 to 1,796,597 to comply with Nasdaq listing rules.

AI Assistant

BIONEXUS GENE LAB CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.